These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 9375283)
1. Role of metal-catalyzed oxidation reactions in the early pathogenesis of scleroderma. Rosen A; Casciola-Rosen L; Wigley F Curr Opin Rheumatol; 1997 Nov; 9(6):538-43. PubMed ID: 9375283 [TBL] [Abstract][Full Text] [Related]
2. Scleroderma autoantigens are uniquely fragmented by metal-catalyzed oxidation reactions: implications for pathogenesis. Casciola-Rosen L; Wigley F; Rosen A J Exp Med; 1997 Jan; 185(1):71-9. PubMed ID: 8996243 [TBL] [Abstract][Full Text] [Related]
3. Autoantibodies against nuclear, nucleolar, and mitochondrial antigens in systemic sclerosis (scleroderma). Reimer G Rheum Dis Clin North Am; 1990 Feb; 16(1):169-83. PubMed ID: 2406806 [TBL] [Abstract][Full Text] [Related]
4. Autoantibodies in scleroderma. Pollard KM; Reimer G; Tan EM Clin Exp Rheumatol; 1989; 7 Suppl 3():S57-62. PubMed ID: 2691161 [TBL] [Abstract][Full Text] [Related]
11. Autoantibodies in scleroderma and tightskin mice. Bona C; Rothfield N Curr Opin Immunol; 1994 Dec; 6(6):931-7. PubMed ID: 7710717 [TBL] [Abstract][Full Text] [Related]
12. Antitopoisomerase I monoclonal autoantibodies from scleroderma patients and tight skin mouse interact with similar epitopes. Muryoi T; Kasturi KN; Kafina MJ; Cram DS; Harrison LC; Sasaki T; Bona CA J Exp Med; 1992 Apr; 175(4):1103-9. PubMed ID: 1372644 [TBL] [Abstract][Full Text] [Related]
13. Pathogenesis of scleroderma. Current concepts. Lee EB; Anhalt GJ; Voorhees JJ; Diaz LA Int J Dermatol; 1984 Mar; 23(2):85-9. PubMed ID: 6698691 [No Abstract] [Full Text] [Related]
14. Autoantibody to RNA polymerase I in scleroderma sera. Reimer G; Rose KM; Scheer U; Tan EM J Clin Invest; 1987 Jan; 79(1):65-72. PubMed ID: 2432091 [TBL] [Abstract][Full Text] [Related]
15. U3 snoRNP associates with fibrillarin a component of the scleroderma clumpy nucleolar domain. Herrera-Esparza R; Kruse L; von Essen M; Campos L; Barbosa O; Bollain JJ; Badillo I; Avalos-Díaz E Arch Dermatol Res; 2002 Oct; 294(7):310-7. PubMed ID: 12373336 [TBL] [Abstract][Full Text] [Related]
16. [Immunofluorescence study with an autoantinucleolus antiserum from a scleroderma patient as compared with silver staining]. Young Y Shi Yan Sheng Wu Xue Bao; 1986 Mar; 19(1):39-51. PubMed ID: 2426879 [No Abstract] [Full Text] [Related]
17. Molecular characterization of an autoantigen of PM-Scl in the polymyositis/scleroderma overlap syndrome: a unique and complete human cDNA encoding an apparent 75-kD acidic protein of the nucleolar complex. Alderuccio F; Chan EK; Tan EM J Exp Med; 1991 Apr; 173(4):941-52. PubMed ID: 2007859 [TBL] [Abstract][Full Text] [Related]
18. Systemic sclerosis (scleroderma): specific autoantigen genes are selectively overexpressed in scleroderma fibroblasts. Zhou X; Tan FK; Xiong M; Milewicz DM; Feghali CA; Fritzler MJ; Reveille JD; Arnett FC J Immunol; 2001 Dec; 167(12):7126-33. PubMed ID: 11739535 [TBL] [Abstract][Full Text] [Related]
19. Intracellular autoantigens: diagnostic fingerprints but aetiological dilemmas. Tan EM; Reimer G; Sullivan K Ciba Found Symp; 1987; 129():25-42. PubMed ID: 3315505 [TBL] [Abstract][Full Text] [Related]
20. A radical proposal for the pathogenesis of scleroderma. Murrell DF J Am Acad Dermatol; 1993 Jan; 28(1):78-85. PubMed ID: 8425975 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]